1.
Meriyani H, Sanjaya DA, Juanita RA, Siada NB, Chusna N. Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review. Borneo J Pharm [Internet]. 2025Feb.28 [cited 2025Mar.18];8(1):33-48. Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/7913